Brigham and Women's Hospital

Qynapse, a company that combines artificial intelligence with neuroimaging technology, is reaffirming its commitment to help advance multiple sclerosis (MS) research and care in recognition of World MS Day. World MS Day is officially celebrated on May 30, with global events and activities designed to raise disease awareness.

A newly identified subset of astrocytes — cells long thought to be responsible for simply providing nutrition and support to neurons — can prevent brain inflammation by promoting the destruction of pro-inflammatory immune T-cells, scientists report. Their work also found that the anti-inflammatory activity of this astrocyte subpopulation is dependent on…

The Partners Multiple Sclerosis Center at Brigham and Women’s Hospital has joined BrainStorm Cell Therapeutics in a Phase 2 trial exploring the safety and efficacy of NurOwn in the treatment of progressive multiple sclerosis (MS). This is the fifth and final clinical site participating in…

With the help of 7 Tesla magnetic resonance imaging (MRI), investigators discovered that leptomeningeal enhancement — a radiographic finding indicative of brain inflammation — is more common than previously thought in people with relapsing-remitting multiple sclerosis (RRMS), and is tied to lesions in specific regions of the brain.

Former Massachusetts First Lady Ann Romney, global ambassador for Boston’s Ann Romney Center for Neurologic Diseases at Brigham and Women’s Hospital, will deliver a keynote address at the Biotechnology Innovation Organization’s (BIO) International Convention in San Diego. Romney, who is scheduled to speak June 21, will talk about how her multiple sclerosis (MS)…

A research team at Brigham and Women’s Hospital (BWH) in Boston and the National Institute of Neurological Disorders and Stroke (NINDS) launched a study on people at risk for developing multiple sclerosis (MS), a debilitating disease that affects more than 400,000 people in the United States and about…

The National Multiple Sclerosis Society granted the 2014 Barancik Prize for Innovation in MS Research to Philip Laurence De Jager, MD, PhD, who is a neurologist at Brigham and Women’s Hospital, as well as an associate professor of neurology at the Harvard Medical School. The award, meant to…